At present there are no restrictions on domestic travel therefore no specific discussions have been tabled with the UK Government. The majority of domestic trips are able to go ahead however we are asking that people be cautious when travelling and choosing activities and we are strengthening some mitigating measures in some areas of the visitor and retail economy. The Scottish Government also continues to engage regularly with the UK Government in relation to support for the wider tourism and hospitality industry.

The regulation of insurance providers is a reserved matter and the Competition and Markets Authority may choose to engage if they believe there is a need for consistency across providers.

No leasing, uniform provision and rolling stock maintenance agreements are expected to remain in place with Abellio once the current franchise ends. A number of existing contracts between Abellio ScotRail Ltd and its suppliers will transfer from Abellio ScotRail Ltd to the new operator, ScotRail Trains Limited, on 1 April 2022.

An agreement has been entered into with Abellio Transport Holdings for the retention of the Abellio Shared Services Centre based in Glasgow. This will retain jobs in Glasgow handling all customer service calls and correspondence, payroll services and payment processing facilities.

Decisions on local staffing requirements and recruitment are the responsibility of individual NHS Boards. However, Scottish Government officials are continually engaging with NHS Boards to identify particular areas of concern.

NHS Highland advise that they, like all NHS Scotland boards, are experiencing sustained pressures on their services and a shortage of registered professionals to fill posts. NHS Highland recognises that staff across the organisation are feeling tired and concerned about their ability to provide the high standards of care that they wish to, and are doing all they can to support them.

NHS Highland has been actively managing the situation in partnership with staffside colleagues to understand the greatest areas of pressures and to address these.

This dialogue will continue over winter months, allowing local healthcare providers and Scottish Government to anticipate emerging pressures and implement targeted responses where necessary.

Although NHS Scotland’s staffing levels are at a record high, following nine years of consecutive growth, we are fully aware of the difficult circumstances that Boards and frontline staff are working in. That is why we have announced a record £300 million of investment to support Health Boards and their staff over the coming months.

As part of this investment, NHS Highland is receiving additional in-year and recurring finance to support international recruitment of registered nurses and additional Healthcare Support Workers for acute services. The Board has also received a share of in-year investment to provide additional support to its recruitment team and to recruit an international recruitment lead.

On 14 December I confirmed in my statement to Parliament that the implementation date of Scotland’s Deposit Return Scheme will be 16 August 2023. Accordingly, revised regulations were laid on 15 December which will change the date by which producers are required to register with SEPA to 1 March 2023 (instead of 1 March 2022). Once the revised regulations come into force, the registration window for producers is in effect changed to the period from 1 January 2023 to 28 February 2023.

Since the announcement on 17 March 2021 that ScotRail services will be provided through the Scottish Government’s Operator of Last Resort arrangements on expiry of the current franchise agreement, no costs have been charged for legal work in connection with those arrangements undertaken by solicitors of the Scottish Government Legal Directorate.

In terms of external solicitor costs, works to the value of £157,763 have been charged for to date. At this rate, Transport Scotland would estimate legal expenditure to be under £500,000 by the commencement of ScotRail Trains Ltd services on 1 April. It should be noted that this is a substantially lower amount than might have been expected in support of a rail franchise procurement competition.

This data is not currently available in the format requested. Public Health Scotland (PHS) collect and report vaccine wastage data for Scotland. The latest publication of vaccine wastage data is publicly available in the Public Health Scotland COVID-19 Statistical Report.

A further update will be included in the edition to be published on 15 December 2021.

An Incident Management Team was stood up on 27 November specifically for Omicron. The team has met daily since and continues to do so. The group is chaired by Public Health Scotland’s Incident Directors. The team meets with other UK nations and wider partners to share intelligence on a four nations basis. The team’s composition does not extend to international public health agencies but they do receive information on the latest international situation with Omicron.

The majority of Lateral Flow Tests are distributed through the UK 4 nations National Testing Programme and a detailed breakdown is not available. Information on the number of Lateral Flow Tests used and reported in Scotland is published weekly by Public Health Scotland.

Sport scotland has followed Scottish Government guidance on rent charges for tenants.

sport scotland have been clear that the COVID support fund was there to support any Scottish governing bodies (SGBs) that were in financial difficulty, this includes both tenants and non-tenants. In addition to the COVID support fund, sport scotland released its full annual investment to all SGBs and allowed them to use this flexibly.

sport scotland meet regularly with tenants to discuss both short-term access to offices, in the context of the latest Government guidance, and establish medium to longer-term requirements for office space. These meetings have been well attended and well received by tenants. Going forward, sport scotland is also offering a 10% discount to tenants on next year's rent. This is in recognition of the uncertainty surrounding how often office space will be used.

Following observations on a small number of patients with long COVID symptoms who received an experimental drug called BC 007 at the Universittsklinikum Erlangen in Germany, a trial of this drug as a potential therapy for long COVID is reportedly being planned by this research institute.

Applications from the Scottish clinical research community for research projects on possible treatments for long COVID can be submitted to the independent research funding committees operated by the Scottish Government’s Chief Scientist Office ( Response Mode Funding Schemes – Chief Scientist Office (scot.nhs.uk) ). Applications are assessed through independent expert peer review and funded based on the recommendations of the funding committees. No applications to trial BC 007 have been received for consideration.